secwatch / observer

8-K filed July 8, 2026, 5:29 PM ET ticker CPRX CIK 0001369568

M&A confidence high sentiment neutral materiality 0.75

Catalyst shareholders approve merger with Angelini Pharma; all directors to resign at closing

CATALYST PHARMACEUTICALS, INC.

Stockholders approved merger with Angelini Pharma: 97,340,180 votes for, 1,143,815 against, 242,616 abstentions.
Advisory compensation proposal for named executive officers not approved (30.5M for, 67.5M against); non-binding and not a condition to merger.
All seven directors (McEnany, Daly, Curran, Denkhaus, Harper, Thompson, Tierney) to resign effective at merger closing; no disagreement with company.
Merger closing subject to customary conditions; no expected closing date provided.

item 5.02 item 5.07

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Tamar Thompson

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 8, 2026, 5:29 PM ET

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

Departed

Richard J. Daly

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 8, 2026, 5:29 PM ET

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

Departed

Patrick J. McEnany

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 8, 2026, 5:29 PM ET

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

Departed

David S. Tierney, M.D.

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 8, 2026, 5:29 PM ET

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

Departed

Molly Harper

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 8, 2026, 5:29 PM ET

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

Departed

Donald A. Denkhaus

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 8, 2026, 5:29 PM ET

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

Departed

Daniel J. Curran, M.D.

Director

CPRX · CATALYST PHARMACEUTICALS, INC.

Filed: July 8, 2026, 5:29 PM ET

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Tamar Thompson resigned as Director at CATALYST PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Richard J. Daly resigned as Director at CATALYST PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Patrick J. McEnany resigned as Director at CATALYST PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

David S. Tierney, M.D. resigned as Director at CATALYST PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Molly Harper resigned as Director at CATALYST PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Donald A. Denkhaus resigned as Director at CATALYST PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel J. Curran, M.D. resigned as Director at CATALYST PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.

View on SEC.gov

CATALYST PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-26-298739

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.